Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-26-285578
Filing Date
2026-06-26
Accepted
2026-06-26 16:32:19
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-3 rkda-20260626.htm S-3 363366
2 EX-5.1 rkda-ex5_1.htm EX-5.1 28769
3 EX-23.1 rkda-ex23_1.htm EX-23.1 4449
4 EX-FILING FEES rkda-exfiling_fees.htm   iXBRL EX-FILING FEES 25475
  Complete submission text file 0001193125-26-285578.txt   545544

Data Files

Seq Description Document Type Size
16 EXTRACTED XBRL INSTANCE DOCUMENT rkda-exfiling_fees_htm.xml XML 5128
Mailing Address 5956 SHERRY LANE SUITE 2000 DALLAS TX
Business Address 5956 SHERRY LANE SUITE 2000 DALLAS TX 214-974-8921
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-297072 | Film No.: 261129891
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)